BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31909088)

  • 1. Genome Editing in Patient iPSCs Corrects the Most Prevalent
    Sanjurjo-Soriano C; Erkilic N; Baux D; Mamaeva D; Hamel CP; Meunier I; Roux AF; Kalatzis V
    Mol Ther Methods Clin Dev; 2020 Jun; 17():156-173. PubMed ID: 31909088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells.
    Liu X; Lillywhite J; Zhu W; Huang Z; Clark AM; Gosstola N; Maguire CT; Dykxhoorn D; Chen ZY; Yang J
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070435
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Sanjurjo-Soriano C; Jimenez-Medina C; Erkilic N; Cappellino L; Lefevre A; Nagel-Wolfrum K; Wolfrum U; Van Wijk E; Roux AF; Meunier I; Kalatzis V
    HGG Adv; 2023 Oct; 4(4):100229. PubMed ID: 37654703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USH2A Gene Editing Using the CRISPR System.
    Fuster-García C; García-García G; González-Romero E; Jaijo T; Sequedo MD; Ayuso C; Vázquez-Manrique RP; Millán JM; Aller E
    Mol Ther Nucleic Acids; 2017 Sep; 8():529-541. PubMed ID: 28918053
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ordoñez-Labastida V; Chacon-Camacho OF; Lopez-Rodriguez VR; Zenteno JC
    Mol Vis; 2023; 29():31-38. PubMed ID: 37287646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and Genetic Characteristics in a Cohort of Patients with Usher Genes.
    Feenstra HM; Al-Khuzaei S; Shah M; Broadgate S; Shanks M; Kamath A; Yu J; Jolly JK; MacLaren RE; Clouston P; Halford S; Downes SM
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole genome sequencing for
    Reurink J; Weisschuh N; Garanto A; Dockery A; van den Born LI; Fajardy I; Haer-Wigman L; Kohl S; Wissinger B; Farrar GJ; Ben-Yosef T; Pfiffner FK; Berger W; Weener ME; Dudakova L; Liskova P; Sharon D; Salameh M; Offenheim A; Heon E; Girotto G; Gasparini P; Morgan A; Bergen AA; Ten Brink JB; Klaver CCW; Tranebjærg L; Rendtorff ND; Vermeer S; Smits JJ; Pennings RJE; Aben M; Oostrik J; Astuti GDN; Corominas Galbany J; Kroes HY; Phan M; van Zelst-Stams WAG; Thiadens AAHJ; Verheij JBGM; van Schooneveld MJ; de Bruijn SE; Li CHZ; Hoyng CB; Gilissen C; Vissers LELM; Cremers FPM; Kremer H; van Wijk E; Roosing S
    HGG Adv; 2023 Apr; 4(2):100181. PubMed ID: 36785559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments.
    Aller E; Nájera C; Millán JM; Oltra JS; Pérez-Garrigues H; Vilela C; Navea A; Beneyto M
    Eur J Hum Genet; 2004 May; 12(5):407-10. PubMed ID: 14970843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global spectrum of
    Su BN; Shen RJ; Liu ZL; Li Y; Jin ZB
    Front Aging Neurosci; 2022; 14():948279. PubMed ID: 36034145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Retinitis Pigmentosa: Retinal Organoids Generated From the iPSCs of a Patient With the USH2A Mutation Show Early Developmental Abnormalities.
    Guo Y; Wang P; Ma JH; Cui Z; Yu Q; Liu S; Xue Y; Zhu D; Cao J; Li Z; Tang S; Chen J
    Front Cell Neurosci; 2019; 13():361. PubMed ID: 31481876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
    Dulla K; Slijkerman R; van Diepen HC; Albert S; Dona M; Beumer W; Turunen JJ; Chan HL; Schulkens IA; Vorthoren L; den Besten C; Buil L; Schmidt I; Miao J; Venselaar H; Zang J; Neuhauss SCF; Peters T; Broekman S; Pennings R; Kremer H; Platenburg G; Adamson P; de Vrieze E; van Wijk E
    Mol Ther; 2021 Aug; 29(8):2441-2455. PubMed ID: 33895329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.
    Reiners J; Nagel-Wolfrum K; Jürgens K; Märker T; Wolfrum U
    Exp Eye Res; 2006 Jul; 83(1):97-119. PubMed ID: 16545802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Characteristics and Variation Spectrum of USH2A-Related Retinitis Pigmentosa and Usher Syndrome.
    Li W; Jiang XS; Han DM; Gao JY; Yang ZT; Jiang L; Zhang Q; Zhang SH; Gao Y; Wu JH; Li JK
    Front Genet; 2022; 13():900548. PubMed ID: 36110214
    [No Abstract]   [Full Text] [Related]  

  • 14. USH2A Gene Mutations in Rabbits Lead to Progressive Retinal Degeneration and Hearing Loss.
    Nguyen VP; Song J; Prieskorn D; Zou J; Li Y; Dolan D; Xu J; Zhang J; Jayasundera KT; Yang J; Raphael Y; Khan N; Iannuzzi M; Bisgaier C; Chen YE; Paulus YM; Yang D
    Transl Vis Sci Technol; 2023 Feb; 12(2):26. PubMed ID: 36795064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
    Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
    Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa.
    Diakatou M; Manes G; Bocquet B; Meunier I; Kalatzis V
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126147
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa.
    Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
    Stem Cell Res; 2018 Dec; 33():228-232. PubMed ID: 30453153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa.
    Seyedahmadi BJ; Rivolta C; Keene JA; Berson EL; Dryja TP
    Exp Eye Res; 2004 Aug; 79(2):167-73. PubMed ID: 15325563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases.
    Pendse ND; Lamas V; Pawlyk BS; Maeder ML; Chen ZY; Pierce EA; Liu Q
    Adv Exp Med Biol; 2019; 1185():91-96. PubMed ID: 31884594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unravelling the pathogenic role and genotype-phenotype correlation of the USH2A p.(Cys759Phe) variant among Spanish families.
    Pérez-Carro R; Blanco-Kelly F; Galbis-Martínez L; García-García G; Aller E; García-Sandoval B; Mínguez P; Corton M; Mahíllo-Fernández I; Martín-Mérida I; Avila-Fernández A; Millán JM; Ayuso C
    PLoS One; 2018; 13(6):e0199048. PubMed ID: 29912909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.